Trial Finder Launched in Europe

We have launched the first HD Trial Finder in Europe! The platform makes it easier to find out more about Huntington’s disease (HD) trials and studies in Europe.

We have launched the first HD Trial Finder in Europe! The platform makes it easier to find out more about Huntington’s disease (HD) trials and studies in Europe.

We have launched the first HD Trial Finder in Europe! The platform makes it easier to find out more about Huntington’s disease (HD) trials and studies in Europe.

Exciting results from Wave Trial PRECISION-HD2!

Today, December 30, Wave announced the first preliminary results from the their study PRECISION-HD2. So far the results are very exciting and promising. 

Today, December 30, Wave announced the first preliminary results from the their study PRECISION-HD2. So far the results are very exciting and promising. 

Today, December 30, Wave announced the first preliminary results from the their study PRECISION-HD2. So far the results are very exciting and promising. 

First human gene therapy trial in Huntington’s disease

uniQure is currently developing a gene therapy treatment. In 2019, FDA gave permission to start human trials in the United States. It will be the first gene therapy trial ever in Huntington's disease.

uniQure is currently developing a gene therapy treatment. In 2019, FDA gave permission to start human trials in the United States. It will be the first gene therapy trial ever in Huntington's disease.

uniQure is currently developing a gene therapy treatment. In 2019, FDA gave permission to start human trials in the United States. It will be the first gene therapy trial ever in Huntington's disease.

An amazing conference!

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

previous arrowprevious arrow
next arrownext arrow
Slider

NEWS


Left to right: Anne Lennon Bird, Svein Olaf Olsen and Astri Arnesen.

Unpacking Wave’s PRECISION-HD2 huntingtin-lowering trial announcement

Just before the new year, Wave announced that the drug in the PRECISION-HD2 trial had successfully lowered the concentration of mutant huntingtin in the spinal ...
Read More

Trial Finder Launched in Europe

This Christmas, we launched the first HD Trial Finder in Europe. HD Trial Finder is a platform developed to make it easier for you to ...
Read More

2019 ends with exciting results from Wave PRECISION-HD2 trial!

Today, December 30, Wave announced the first preliminary results from the their study PRECISION-HD2 . So far the results are very exciting and promising. It's ...
Read More

CONTACT US

Astri Arnesen
President